PROAXON

Proaxon was funded in 2003 by Prof John Garthwaite, Dr David Selwood and Dr Giti Garthwaite (Wolson Institute, UCL).

The company has developed a set of biological assays designed to identify novel sodium channel blockers for slowing down or even preventing neurodegeneration.

ProAxon has already identified several chemical series with very exciting properties.